Approach to the new oral anticoagulants in family practice: part 1: comparing the options.
about
Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questionsAreas of improvement in anticoagulant safety. Data from the CACAO study, a cohort in general practice.Well-managed warfarin is superior to NOACs.Checklists for the use of novel oral anticoagulants by the front-line clinician.Pharmacist Interventions Regarding the Appropriateness of Apixaban, Rivaroxaban, Dabigatran, and Warfarin in a University-Affiliated Outpatient Clinic.
P2860
Approach to the new oral anticoagulants in family practice: part 1: comparing the options.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Approach to the new oral antic ...... part 1: comparing the options.
@ast
Approach to the new oral antic ...... part 1: comparing the options.
@en
Approach to the new oral antic ...... part 1: comparing the options.
@nl
type
label
Approach to the new oral antic ...... part 1: comparing the options.
@ast
Approach to the new oral antic ...... part 1: comparing the options.
@en
Approach to the new oral antic ...... part 1: comparing the options.
@nl
prefLabel
Approach to the new oral antic ...... part 1: comparing the options.
@ast
Approach to the new oral antic ...... part 1: comparing the options.
@en
Approach to the new oral antic ...... part 1: comparing the options.
@nl
P2093
P2860
P1476
Approach to the new oral anticoagulants in family practice: part 1: comparing the options
@en
P2093
Alan David Bell
James Douketis
John Eikelboom
P2860
P304
P407
P50
P577
2014-11-01T00:00:00Z